Marine actinomycete taxon for drug and fermentation product...

Details Marine actinomycete taxon for drug and fermentation product... Marine actinomycete taxon for drug and fermentation product...

2006-12-05

2006-12-05

Marx, Irene (Department: 1651)

Chemistry: molecular biology and microbiology

Micro-organism, per se ; compositions thereof; proces of...

Bacteria or actinomycetales; media therefor

C424S093400

Reexamination Certificate

active

07144723

ABSTRACT:
The invention is the discovery of an actinomycete genus, given the nameSalinosporagen. nov., that displays an obligate requirement of seawater (Na+) for growth and unique 16S rRNA signature nucleotides. The invention is also the use of the genus for the production and discovery of active biomolecules such as pharmaceutical agents, agrichemicals, immunomodifiers, enzymes and enzyme inhibitors.

REFERENCES:
patent: 5756764 (1998-05-01), Fenteany et al.
patent: 6133308 (2000-10-01), Soucy et al.
patent: 6147223 (2000-11-01), Fenteany et al.
patent: 6214862 (2001-04-01), Fenteany et al.
patent: 6294560 (2001-09-01), Soucy et al.
patent: 6335358 (2002-01-01), Fenteany et al.
patent: 6458825 (2002-10-01), Fenteany et al.
patent: 6566553 (2003-05-01), Soucy et al.
patent: 6645999 (2003-11-01), Schreiber et al.
patent: 6794516 (2004-09-01), Soucy et al.
patent: 6838477 (2005-01-01), Schreiber et al.
patent: 6849743 (2005-02-01), Soucy et al.
patent: 2001/0002391 (2001-05-01), Brand et al.
patent: 2001/0051654 (2001-12-01), Elliott et al.
patent: 2004/0138196 (2004-07-01), Fenical et al.
patent: WO 96/32105 (1996-10-01), None
patent: WO96/32105 (1996-10-01), None
patent: WO 99/09006 (1999-02-01), None
patent: WO00/23614 (2000-04-01), None
patent: WO/02/47610 (2002-06-01), None
patent: WO 02/47610 (2002-06-01), None
patent: WO/2004/071382 (2004-08-01), None
patent: WO 2004/071382 (2004-08-01), None
patent: WO/2005003137 (2005-01-01), None
Bull, A. T. et al. 2000. Search and discovery strategies for biotechnology: The paradigm shift. Microbiology and Molecular Biology Reviews. 64:573-606.
Goodfellow, M. et al. 1984. Actinomycetes in marine sediments, p. 453-472. Biological, biochemical, and biomedical aspects of actinomycetes. Academic Press, Inc. Orlando.
Goodfellow, M. et al. 1983. Ecology of actinomycetes. Ann. Rev. Microbiol. 37:189-216.
Helmke, E. et al. 1984.Rhodococcus marinonascenssp. nov., an actinomycete from the sea. Int. J. Syst. Bacteriol. 34:127-38.
Hopwood, D.A. 1995. Genetic manipulation of streptomyces polyketide synthase genes for novel secondary metabolite production. FEMS Microbiol. Rev. 16:233-4.
Jensen, P.R., et al. 1991. Distribution of actinomycetes in near-shore tropical marine sediments. Appl. Environ. Microbiol 57:1102-8.
Koch, C., et al. 1996. 16S ribosomal DNA analysis of the genera Micromonospora, Actinoplanes, . . . Int. Journal of Systematic Bacteriology. 46:765-768.
Moran, M.A. et al. 1995. Evidence for indigenous streptomyces populations in a marine environment . . . , pp. 3695-3700. Applied and Environmental Microbiology. vol. 61, No. 10.
Nesternenko, O.A., et al. 1982Rhodococcus luteusnom, nov. andRhodococcus marisnom. nov. pp. 1-14. Int'l Journal of Systematic Bacteriology. vol. 32, No. 1.
Nolan, R.D. et al. 1988. Isolation and screening of actinomycetes, pp. 1-32. Actinomycetes in Biotechnology.
O'Donnell, A.G. 1988. Recognition of novel actinomycetes, pp. 69-88. Actinomycetes in Biotechnology.
Okami, Y. et al. 1988. Search and discovery of new antibiotics,pp. 33-67. Actinomyetes in Biotechnology.
Page, R. D. M. 1996. TREEVIEW: An application to display phylogenetic trees on personal computers. Computer Applications in the Biosciences 12, 357-358.
Stackebrandt, E. et al. 1997. Proposal for a new hierarchic classification system, Actinobacteria classis nov. International Journal of Systematic Bacteriology. 47:479-491.
Tang, L. et al. 2000. Cloning and heterologous expression of the epothilong gene cluster. Science. 287:640-2.
Thompson, J.D. et al. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, . . . Nucleic Acids Research 22:4673-4680.
Versalovic, J. et al. 1991. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 19:6823-6831.
Weyland, H. 1981. Distribution of actinomycetes on the sea floor. Actinomycetes, Zbl. Bakt. Suppl. 11:185-193.
Hardt et al., “Neomarinone, and new cytotoxic marinone derivatives, produced by a marine filamentous bacterium (actinomycetales)”,Tetrahedron Letters, Mar. 2000, 41(13):2073-6.
Jensen et al., “The Relative Abundance and Seawater Requirements of Gram-Positive Bacteria in Near-Shore Tropical Marine Samples”,Microb Ecol., 1995, 29(3):249-57.
Jiang et al., “Actinoflavoside, A Novel Flavonoid-Like Glycoside Produced by a Marine Bacterium of the GenusStreptomyces”, Tetrahedron Letters, 38(29):5065-8.
Feling et al., Angew. (2003) Angew. Chem. Int. Ed. 42(3):355-357.
Fusetani (ed.):Drugs from the Sea.Basel, Karger 2000, pp. 6-29.
Davidson, B.S., Current Opinion in Biotechnology 1995, 6:284-291.
Blunt, J.W., et al., Nat. Prod. Rep., 2003, 20:1-48.
Colquhoun, J.A., et al., Extremophiles, 1998, 2:269-277.
Fenical, W., Chem. Rev. 1993, 93:1673-1683.
Fenical, W., Marine Biotechnology 1997, 15:339-341.
Fernandez-Chimeno R.I., et al., Journal of Antibiotics, 2000 53(5):474-478.
Goodfellow and O'Donnell, (1989) Search and discovery of industrially significant actinomycetes. InMicrobial Products: New Approaches, Society for General Microbiology Symposium No. 44eds Baumberg, S., et al., pp. 343-383. Cambridge: Cambridge University Press.
Horan, A.C. “Aerobic Actinomycetes: A Continuing Source of Novel Natural Products.” In Gullo, V.P. (ed.),The Discovery of Natural Products with Therapeutic Potential.Boston: Butterworth-Heinemann, 1994, pp. 1-30.
Romero, F., et al., The Journal of Antibiotics, 1997, 50(9):734-737.
Watve, M.G. et al., 2001, Arch. Microbiol 176:386-390.
Weyland, J., Nature, 1969, 223:858.
Zheng, Z, et al., FEMS Microbiology Letters, 2000, 188:87-91.
Mincer, T.J., et al., Appl. Environ. Microbiol., 2002, 68(10):5005-5011.
He, H., et al., J. Am. Chem. Soc., 2001, 123:5362-5363.
Stach, J.E.M., et al., Appl. Environ. Microbiol., 2003, 69(10):6189-6200.
Colquhoun, J.A., et al., Antonie van Leeuwenhoek, 1998, 74:27-40.
Stach, J.E.M. et al., Envion. Microbiol., 2003, 5(10):828-841.
Elliott, P.J. et al., J. Mol. Med., 2003, 81:235-245/.
Joseph, S.J., et al., 2003, Appl Environ. Microbiol. 69(12):7210-7215.
Otoguro, M., et al., J. Appl. Microbiol., 2001, 92:118-130.
Cheng, X.C., et al., J. Nat. Prod., 1999, 62:608-610.
Cheng, X.C., et al., J. Nat. Prod. 1999, 62:605-607.
Erba, E., et al., British Journal of Cancer, 1999, 88(7):971-980.
Beman, V.S., et al., Advances in Applied Microbiology 1997, 43:57-90.
Jenson and Fenical, Annu. Rev. Microbiol 1994, 48:559-84.
Okami, Y., Journal of Marine Biotechnology 1993, 1:59-65.
Goodfellow and O'Donnell, (1988) “Actinomycetes in Biotechnology”, Okami, et al., ed.,Search and Discovery of New Antibiotics.Academic Press: San Diego 1988, pp. 33-67.
Beers, et al., “The Merck Manual of Diagnosis & Therapy” Seventeenth Edition, Merck Research Lab. pp. 1157, col. 2, p. 1158 col. 2, p. 1241, col. 2, p. 1252, col. 1, Whitehouse Station NJ (1999).
Crane, et al., “A Novel Enantioselective Synthetic Route to Omuralide Analogues with te Potential for Species Selectivity in Proteasome Inhibition”, Organic Letters 3(9):1395-1397 (2001).
DeLong, et. al., “Environmental Diversity of Bacteria and Archaea”,Syst. Biol.50(4):470-478, (2001).
Elliott, et al., “The proteasome: A new Target for Novel Drug Therapies”, Am. J. of Clin Pathology. 116(5):637-646 (2001).
Feling, et al., “Salinospormide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, A Marine Bacterium of the New GenusSalinospora” Angewandte Chemie(Intl. ed. In English), 2003 pp. 355-357.
Fenical, et al., “Marine Microorganisms as a Developing Resource for Drug Discovery”,Pharmaceutical News, 9/6, 489-494 (2002).
Gantt, et al., “proteasome Inhibitors Block Development of Plasmodium Spp”, Antimicrobial Agents and Chemotherapy 42(10):2731-2738 (1998).
Giovannoni, Steven, “Oceans of Bacteria”,Nature430:515-516, (Jul. 29, 2004).
Goldberg, et al., “Not Just Research Tools-proteasome Inhibitors Offer The

Affiliated with

Also associated with

Rating

Marine actinomycete taxon for drug and fermentation product... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Marine actinomycete taxon for drug and fermentation product..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Marine actinomycete taxon for drug and fermentation product... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3717704